2 Annex 8 Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services Background 1. Introduction 2. Underlying philosophy 3. Definition of good pharmacy practice 4. Requirements of good pharmacy practice 5. Setting standards for good pharmacy practice 6. Conclusions
3 Background Under the World Health Organization (WHO) s Revised Drug Strategy adopted by the World Health Assembly in 1986, WHO organized two meetings on the role of the pharmacist, in Delhi, India in 1988 and in Tokyo, Japan in This was followed by the adoption, in May 1994, of the World Health Assembly Resolution WHA47.12 on the role of the pharmacist, in support of the WHO Revised Drug Strategy. In 1992 the International Pharmaceutical Federation (FIP) developed standards for pharmacy services under the heading Good pharmacy practice in community and hospital pharmacy settings. The text on good pharmacy practice was also submitted to the WHO Expert Committee on Specifications for Pharmaceutical Preparations in Following the recommendations of the WHO Expert Committee and the endorsement of the FIP Council in 1997, the FIP/WHO joint document on good pharmacy practice (GPP) was published in 1999 in the thirty-fifth report of the WHO Expert Committee on Specifi cations for Pharmaceutical Preparations (WHO Technical Report Series, No. 885). Subsequently WHO organized two more meetings on the role of the pharmacist, in Vancouver, Canada in 1997 and in the Hague, the Netherlands in These meetings reinforced the need for pharmacy curricular reform and the added value of the pharmacist in self-care and self-medication. In collaboration with WHO, the fi rst edition of a practical handbook Developing pharmacy practice a focus on patient care was launched in This handbook is designed to meet the changing needs of pharmacists, setting out a new paradigm for pharmacy practice and presenting a step-by-step approach to pharmaceutical care. With the overall aim of improving standards and practice of distribution and use of medicines, using the FIP/WHO guidelines for GPP as the framework, FIP took the initiative to explore the possibilities for providing technical assistance to its Member Organizations in Cambodia, Moldova, Mongolia, Paraguay, Thailand, Uruguay and Viet Nam, in developing national standards for GPP in a pilot study from 2005 to In 2007 the Bangkok declaration on good pharmacy practice in the community pharmacy settings in the South-East Asia Region was adopted by the FIP South-East Asia Pharmaceutical Forum and set out the commitment of its Member Associations towards raising standards of pharmacy services and professional practice. Since the adoption of the GPP guidelines in community and hospital settings, significant changes in practice, applied science and technology and pharmaceutical policy have occurred, including the relevance of more recent World Health Assembly
4 resolutions: WHA54.11 (WHO Medicines Strategy), WHA54.13 (Strengthening health systems in developing countries), WHA55.14 (Ensuring accessibility of essential medicines), WHA55.18 (Quality of care: patient safety), WHA57.16 (Health promotion) and WHA60.16 (Rational use of medicines). Furthermore, in 2007 FIP established an initiative to investigate the need to update the guidelines on GPP to reflect contemporary standards of practice and thinking. An FIP working group on GPP first met on 15 October 2007 to identify key issues that needed to be considered in the revision of the guidelines. In 2008 FIP organized an expert consultation in Basel, Switzerland during its 68th World Congress. Fifty participants attended the meeting, including the FIP Working Group (WG) on GPP, WHO staff from headquarters, representatives from the WHO Regional Office for the Eastern Mediterranean, country medicines advisers from Ghana, Nigeria and the United Republic of Tanzania, Presidents and Secretaries of the six FIP Regional Pharmaceutical Forums, FIP Member Organizations and several invited experts. Following this consultation, the FIP WG on GPP undertook an extensive review of the existing national standards on GPP in at least 37 countries and established a time frame that would allow sufficient consultation with all of FIP s 120 national Member Associations, relevant experts and WHO. A proposal for this initiative was presented to the forty-third meeting of the WHO Expert Committee on Specifi cations for Pharmaceutical Preparations in October 2008 and an updated report was provided to the Expert Committee at its forty-fourth meeting in October Introduction The health of the public is fundamental to the happiness and welfare of all people. Barriers to good health include poor access to quality medical products, lack of access to trained health professionals and care, an inadequate health workforce, unaffordable cost of care and poor standards of education of health-care professionals. Medicines are an essential and critical part of health-care services in all cultures and societies. When accessed, medicines are often an essential component of many disease prevention programmes and virtually all disease treatment plans. The potential benefit of medicines is often not realized there is a gap between the proven efficacy of medicines demonstrated in clinical trials and their actual effectiveness in practice. The reasons for this gap include problems with medicine selection and dosages, improper administration of medicines and lack of adherence by patients to prescribed treatment, medicine medicine and medicine food interactions, and adverse medicine events. Besides clinical problems associated with medicine-
5 related problems, there are cost implications. It has been estimated that the cost of problems with the use of medicines is equal to or greater than the cost of the medicines themselves. Medicines are also increasingly expensive and their cost is compromising the affordability of health care. Managing the costs of medicines is critical to making the best use of limited resources to maximize health care for as many people as possible. Substandard, adulterated, unlicensed and spurious/falsely-labelled/falsified/ counterfeit medicines are a growing problem that compromise health. There is a need for a system of assuring the integrity of the medicine supply chain to assure the value of medicines used for the prevention of disease and the treatment of patients. Pharmacists 1 are specifically educated and trained health professionals who are charged by their national or other appropriate (e.g. state or provincial) authorities with the management of the distribution of medicines to consumers and to engage in appropriate efforts to assure their safe and efficacious use. There is also increasing recognition that providing consumers with medicines alone is not suffi cient to achieve the treatment goals. To address these medication-related needs, pharmacists are accepting greater responsibility for the outcomes of medicines use and are evolving their practices to provide patients with enhanced medicines-use services. As health-care professionals, pharmacists play an important role in improving access to health care and in closing the gap between the potential benefit of medicines and the actual value realized and should be part of any comprehensive health system. In addition, the increasingly complex and diverse nature of pharmacists roles in the health-care system and public health demands a continuous maintenance of the competence of pharmacists as health-care professionals who have up-to-date skills and expertise. National pharmacy professional associations need to work together with their governing bodies and other health-care professional associations to support pharmacists in their countries through provision of continuing professional development activities, including distance-learning programmes, and establishing national standards of pharmacy services and practice objectives. These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for national 1 Pharmacists are health-care professionals whose professional responsibilities and accountabilities include seeking to ensure that people derive maximum therapeutic benefit from their treatments with medicines. This requires them to keep abreast of developments in pharmacy practice and the pharmaceutical sciences, professional standards and requirements, the laws governing pharmacy and medicines and advances in knowledge and technology relating to use of medicines.
6 pharmacy professional organizations, which in turn provide the impetus for setting national standards. 2 The vital element is the commitment of the pharmacy profession worldwide to promoting excellence in practice for the benefit of those served. The public and other professions will judge the pharmacy profession on how its members translate that commitment into practice in all settings, especially community and hospital pharmacy settings. It is the policy of FIP and WHO to provide guidance to national pharmacy professional organizations regarding the development of their national GPP guidelines. The conditions of practice vary widely from country to country and each national pharmacy professional organization is best able to decide what can be achieved and within what time-scale. 2. Underlying philosophy The mission of pharmacy practice is to contribute to health improvement and to help patients with health problems to make the best use of their medicines. There are six components to this mission: being readily available to patients with or without an appointment; identifying and managing or triaging health-related problems; health promotion; assuring effectiveness of medicines; preventing harm from medicines; and making responsible use of limited health-care resources. In the community setting, pharmacists should be acknowledged as health-care professionals whom patients can consult for health-related problems. Because health-care products and services are available from the pharmacist, some problems can be managed at this point of care. Problems that require additional diagnostic skill or treatments not available from a pharmacist can be referred to an appropriate health-care professional or site of care, such as a hospital. This should be done in good collaboration between the health-care providers. To improve the use of medicines, pharmacists have responsibilities for many aspects of the process of medicines use, each of which is important to achieve good outcomes from treatment. This begins with assuring the integrity of the medicine supply chain, including detecting spurious/falsely-labelled/falsified/counterfeit medicines, ensuring proper storage of medicines and quality preparation of medicines when needed. It also includes assuring the proper prescribing of medicines so that dose regimens and 2 Throughout this document, the term national standards includes laws, regulations, standards, ordinances or other requirements enacted or promulgated by an official body at any level of government, as well as guidelines, recommendations or other pronouncements of professional organizations of pharmacy.
7 dosage forms are appropriate; instructions for use are clear; medicine medicine and medicine food interactions are prevented; known and predictable adverse medicine reactions, including allergies and other contraindications, are avoided; unnecessary treatments are minimized and the cost of medicines is considered. Another important component of this mission is assisting patients and those administering medicines to understand the importance of taking medicines properly, including the correct timing of doses, foods or other medicines to avoid when taking a dose and what to expect after taking the medicine. Monitoring treatment to verify effectiveness and adverse medicine events is also an important part of the process of use of medicines. 3. Definition of good pharmacy practice GPP is the practice of pharmacy that responds to the needs of the people who use the pharmacists services to provide optimal, evidence-based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines. 4. Requirements of good pharmacy practice GPP requires that a pharmacist s first concern in all settings is the welfare of patients. GPP requires that the core of the pharmacy activity is to help patients make the best use of medicines. Fundamental functions include the supply of medication and other health-care products of assured quality, the provision of appropriate information and advice to the patient, administration of medication, when required, and the monitoring of the effects of medication use. GPP requires that an integral part of the pharmacist s contribution is the promotion of rational and economic prescribing, as well as dispensing. GPP requires that the objective of each element of pharmacy service is relevant to the patient, is clearly defined and is effectively communicated to all those involved. Multidisciplinary collaboration among health-care professionals is the key factor for successfully improving patient safety. In satisfying these requirements, the following conditions are necessary: the well-being of patients should be the main philosophy underlying practice, even though it is accepted that ethical and economic factors are also important; pharmacists should have input into decisions about the use of medicines. A system should exist that enables pharmacists to report and to obtain feedback about adverse events, medicine-related problems, medication errors, misuse or medicine abuse, defects in product quality or detection of counterfeit products. This reporting
8 may include information about medicine use supplied by patients or health professionals, either directly or through pharmacists; the relationship with other health professionals, particularly physicians, should be established as a therapeutic collaborative partnership that involves mutual trust and confidence in all matters relating to pharmacotherapy; the relationship between pharmacists should be one of colleagues seeking to improve pharmacy service, rather than acting as competitors; in reality, organizations, group practices and pharmacy managers should accept a share of responsibility for the definition, evaluation and improvement of quality; the pharmacist should be aware of essential medical and pharmaceutical information (i.e. diagnosis, laboratory test results and medical history) about each patient. Obtaining such information is made easier if the patient chooses to use only one pharmacy or if the patient s medication profile is available; the pharmacist needs evidence-based, unbiased, comprehensive, objective and current information about therapeutics, medicines and other health-care products in use, including potential environmental hazard caused by disposal of medicines waste; pharmacists in each practice setting should accept personal responsibility for maintaining and assessing their own competence throughout their professional working lives. While self-monitoring is important, an element of assessment and monitoring by the national pharmacy professional organizations would also be relevant in ensuring that pharmacists maintain standards and comply with requirements for continuous professional development; educational programmes for entry into the profession should appropriately address both current and foreseeable changes in pharmacy practice; and national standards of GPP should be specified and should be adhered to by practitioners. At the national or appropriate (e.g. state or provincial) level, it is necessary to establish: A legal framework that: - defines who can practice pharmacy; - defines the scope of pharmacy practice; - ensures the integrity of the supply chain and the quality of medicines. A workforce framework that: - ensures the competence of pharmacy staff through continuing professional development (CPD or continuing education (CE)) programmes; - defines the personnel resources needed to provide GPP.
9 An economic framework that: - provides sufficient resources and incentives that are effectively used to ensure the activities undertaken in GPP. 5. Setting standards for good pharmacy practice GPP includes standards that often exceed those laid down by national legislation. Furthermore, legislation seldom gives precise instructions about how the services should be produced to meet the requirements. Therefore, national pharmacy professional associations have a role in setting standards required for GPP, which includes a quality management framework and a strategic plan for developing services. It is also recognized that in developing national standards for GPP, attention must be paid to both the needs of the users of health-care services and the capacity of national health-care systems to support these services. Just as pharmacy practice will vary among nations, it will also vary among practice locations. Therefore, standards should recognize the uniqueness of different pharmacy practice settings (e.g. community and hospital pharmacy). In addition, as medicines and needs change, the standards should acknowledge evolving practice settings and provide these developing services with guidance without negatively affecting the evolutionary nature of practice. At the same time, a baseline should be established for practice below which the activity cannot be considered pharmacy practice at all and, therefore, should not be condoned. When establishing minimum standards on GPP, FIP emphasizes the importance of first defining the roles played by pharmacists, as expected by patients and society. Secondly, relevant functions for which pharmacists have direct responsibility and accountability need to be determined within each role. Thirdly, minimum national standards should then be established, based upon the need to demonstrate competency in a set of activities supporting each function and role. The minimum national standards for each activity are based on processes that need to be relevant and defined appropriately according to the local needs of the pharmacy practice environment and national profession aspirations. All national pharmacy professional associations should also adapt these roles and functions in accordance to their own requirements. The activities listed below can be further defined and measured by setting indicators of good practice within a national context and can be weighted by actual practice-setting priorities. It is recommended that national pharmacy professional associations consider the following roles, functions and activities for pharmacists, where appropriate:
10 Role 1: Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products Function A: Prepare extemporaneous medicine preparations and medical products - Pharmacists should ensure that medicine preparation areas are appropriately designed to permit ease of extemporaneous preparations and are maintained in a manner that minimizes the potential for medication errors and assures the cleanliness and safety of medical products. - Pharmacists should ensure that compounded medicines are consistently prepared to comply with written formulas and quality standards for raw materials, equipment and preparation processes, including sterility where appropriate. Function B: Obtain, store and secure medicine preparations and medical products - Pharmacists who are responsible for procurement should ensure that the procurement process is transparent, professional and ethical so as to promote equity and access and to ensure accountability to relevant governing and legal entities. - Pharmacists who are responsible for procurement should ensure that procurement is supported by strong quality assurance principles to assure that substandard, adulterated, unlicensed and spurious/falsely-labelled/falsified/counterfeit medicines are not procured or allowed into the system. - Pharmacists who are responsible for procurement should ensure that procurement is supported by a reliable information system which provides accurate, timely and accessible information. - Pharmacists should establish contingency plans for shortages of medicines and for purchases in emergencies. - Pharmacists should assure that proper storage conditions are provided for all medicines, especially for controlled substances, used in the pharmacy or health-care facility. Function C: Distribute medicine preparations and medical products - Pharmacists should ensure that all medical products, including medicine samples, are handled and distributed in a manner that assures reliability and safety of the medicine supply.
11 - Pharmacists should establish an effective distribution system which includes a written procedure, to recall promptly and effectively medical products known or suspected to be defective or spurious/falsely-labelled/falsified/counterfeit, with a designated person(s) responsible for recalls. - Pharmacists should develop with manufacturers, wholesalers and government agencies (where appropriate) an access plan for uninterrupted supply of essential medicines as part of a disaster or pandemic preparedness strategy. - As part of a disaster or pandemic preparedness strategy, national medicines regulatory agencies may introduce new medicines which are authorized for marketing with limited safety data; pharmacists have a responsibility to be aware of the safety issues and to institute necessary mechanisms for monitoring occurrence of adverse events. Function D: Administration of medicines, vaccines and other injectable medications - Pharmacists should have a role in the preparation and administration of medicines, in establishing procedures in their work settings with respect to the administration, and in monitoring the outcomes of medication administration. - Pharmacists should have an educator, facilitator and immunizer role, thus contributing to the prevention of diseases through participation in vaccination programmes, by ensuring vaccination coverage and by also ensuring vaccine safety. - Pharmacists should participate in directly observed therapy (DOT) programmes in areas such as the management of drug addiction, HIV/AIDS, tuberculosis and sexually transmitted diseases, where applicable. Function E: Dispensing of medical products - Pharmacists should ensure that appropriate facilities, trained personnel, standard dispensing practices and documentation procedures are in place in the pharmacy for the supply and dispensing of prescribed medicines and other health-care products. - Pharmacists should assess and evaluate all paper or electronic prescriptions received, considering the therapeutic, social, economic and legal aspects of the prescribed indication(s) before supplying medical products to the patient. Where possible, generic substitution is recommended.
12 - Pharmacists should ensure patient confi dentiality at the point of dispensing medical products and should provide advice to ensure that the patient receives and understands suffi cient written and oral information to derive maximum benefit for the treatment. Function F: Dispose of medicine preparations and medical products - Pharmacists should ensure that regular monitoring of the medicines inventory is conducted and should always include medicines samples in the process of periodic inspection for expiration dates and removal of outdated stock. - Pharmacists should ensure that recalled medical products, including medicines samples, are immediately stored separately for subsequent disposal and prevented from being available for further dispensing or distribution. - Pharmacists should establish a safe way of medicines waste disposal at the hospital and/or community pharmacy so that patients and the public can be encouraged to return their expired or unwanted medicines and medical devices. Alternatively, pharmacists should provide appropriate information to patients on how to safely dispose of expired or unwanted medicines. Role 2: Provide effective medication therapy management 3 Function A: Assess patient health status and needs - Pharmacists should ensure that health management, disease prevention and healthy lifestyle behaviour are incorporated into the patient assessment and care process. - Pharmacists should acknowledge unique patient considerations such as education level, cultural beliefs, literacy, native language and physical and mental capacity in all individual patient assessments. Function B: Manage patient medication therapy - Pharmacists should maintain access to an appropriate evidence base relating to the safe, rational and cost-effective use of medicines such as reference books on medicines, journals, national essential medicines lists and standard treatment guidelines. 3 Medication therapy management is a distinct service or group of services that optimize therapeutic outcomes for individual patients. Medication therapy management services are independent of, but can occur in conjunction with, the provision of a medication product.
13 - Pharmacists should ensure that medicine formulary system(s) (local, regional and/ or national) are linked to standard treatment guidelines, protocols and treatment pathways based on the best available evidence. - Pharmacists should have a key role in educating prescribers on the access to and evidence for optimal and appropriate use of medicines including the required monitoring parameters and prescribing adjustments. Where appropriate, pharmacists should provide advice or recommendations to the prescriber on medicine therapy, including the selection of the appropriate medication or dosage. - Pharmacists should have access to, contribute to and use all necessary clinical and patient data to coordinate effective medication therapy management, especially when multiple health-care practitioners are involved in the patient s medication therapy, and intervene if necessary. - Pharmacists should establish a standard operating procedure for referrals to physicians, specialists or other health-care providers, where appropriate. - Pharmacists should provide continuity of care by transferring information on patients medicines as patients move between sectors of care. Function C: Monitor patient progress and outcomes - Pharmacists should consider patient diagnosis and patient-specific needs when assessing patient response to medicine therapy and intervene if necessary. - Pharmacists should document necessary clinical and patient data to assess and monitor medication therapy and to track patients therapeutic outcomes. - Pharmacists should perform point-of-care testing for patients in order to monitor and adjust therapy, when needed. Function D: Provide information about medicines and health-related issues - Pharmacists should ensure that in every pharmacy there is a suitable place for discussing confi dential information with the customers and patients. - Pharmacists should provide sufficient health, disease and medicinespecific information to patients for their participation in their decision-making process
14 regarding a comprehensive care management plan. This information should aim at supporting adherence to treatment and empowerment of the patient. - Pharmacists should be proactive in reducing antimicrobial resistance by providing information about the appropriate use of antimicrobials to consumers and prescribers. Role 3: Maintain and improve professional performance Function A: Plan and implement continuing professional development 4 strategies to improve current and future performance - Pharmacists should perceive continuing education as being lifelong and be able to demonstrate evidence of continuing education or continuing professional development to improve clinical knowledge, skills and performance. - Pharmacists should take steps to update their knowledge and skills about complementary and alternative therapies such as traditional Chinese medicines, health supplements, acupuncture, homeopathy and naturopathy. - Pharmacists should take steps to update their knowledge and be engaged in implementation of new technology and automation in pharmacy practice, where feasible. - Pharmacists should take steps to become informed and update their knowledge on changes to information on medical products. Role 4: Contribute to improve effectiveness of the health-care system and public health Function A: Disseminate evaluated information about medicines and various aspects of self-care - Pharmacists should ensure that the information provided to patients, other healthcare professionals and the public is evidence-based, objective, understandable, nonpromotional, accurate and appropriate. - Pharmacists should develop and/or use educational materials for health management, health promotion and disease prevention programmes that are applicable to a wide range of patient populations, age groups and health literacy levels. 4 The concept of continuing professional development (CPD) can be defined as the responsibility of individual pharmacists for systematic maintenance, development and broadening of knowledge, skills and attitudes, to ensure continuing competence as a professional, throughout their careers.
15 - Pharmacists should educate patients on how to evaluate and use web-based or other forms of health-care information (including medicines information) and strongly encourage them to be advised by a pharmacist regarding the information they fi nd, particularly if obtained from the Internet. - Pharmacists should assist patients and their care providers to obtain and critically analyse information to meet their individual needs. Function B: Engage in preventive care activities and services - Pharmacists should engage in preventive care activities that promote public health and prevent disease, i.e. in areas such as smoking cessation, infectious and sexually transmitted diseases. - Pharmacists should provide point-of-care testing, where applicable, and other health screening activities for patients at higher risk of disease. Function C: Comply with national professional obligations, guidelines and legislations - Pharmacists should take steps to ensure that they comply with the provisions of a national code of ethics for pharmacists. Function D: Advocate and support national policies that promote improved health outcomes - Pharmacists should contribute to public and professional groups to promote, evaluate and improve health in the community - Pharmacists should collaborate with other health-care professionals in their efforts to improve health outcomes.
16 6. Conclusions There are four main roles where pharmacists involvement or supervision is expected by society and the individuals they serve: 1. Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products. 2. Provide effective medication therapy management. 3. Maintain and improve professional performance. 4. Contribute to improve effectiveness of the health-care system and public health. These roles may vary for each individual pharmacist depending on their practice responsibilities. Specific standards of GPP can be developed only within a national pharmacy professional organization framework. This guidance is recommended as a set of professional goals to be met in the interest of the patients and other key stakeholders in the pharmaceutical sector. Responsibility for moving the project forward will rest with each national pharmacy professional association. Achieving specific standards of GPP for each nation within these recommendations may require considerable time and effort. As health professionals, pharmacists have a duty to begin the process without delay.
Introduction Good Pharmacy Practice (GPP) is at the very heart of the profession of Pharmacy; indeed it is the very essence of the profession. Moreover, it expresses our covenant with the patient not only
University of Washington School of Pharmacy Care Definition, Practice Foundations, and Ability-Based Outcomes The pharmacist graduating from the University of Washington School of Pharmacy promotes the
A competency framework for all prescribers updated draft for consultation Consultation closes 15 April 2016 Contents 1 Introduction... 3 2 Uses of the framework... 4 3 Scope of the competency framework...
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
Scope of Practice for Registered Nurses (RN) Health Regulation Department Dubai Health Authority (DHA) email@example.com DHA hotline tel. no: 800 DHA (342) www.dha.gov.ae Introduction Health Regulation
Understanding Alberta s Drug Schedules Preface In May 2002, the provincial drug schedules to the Pharmaceutical Profession Act were amended. In April 2007, the Alberta Regulation 66/2007 to the Pharmacy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
35 Access to affordable essential medicines 1 Target 8e In cooperation with pharmaceutical companies, provide access to affordable essential drugs in developing countries. Target 8e of the Millennium Development
Legislation and regulations affecting pharmacists practice guidelines vary according to the legislative styles and practices of each state. The following information highlights the legislative elements
Pharmacists Patient Care Process May 29, 2014 Joint Commission of Pharmacy Practitioners The Joint Commission of Pharmacy Practitioners (JCPP) was established in 1977 and serves as a forum on matters of
Orientating statements Nurse practitioners have the capability to provide high levels of clinically focused nursing care in a variety of contexts in Australia. Nurse practitioners care for people and communities
Guidelines for Education Requirements for Recognition as Eligible Midwives and Accreditation Standards for programs of study leading to endorsement for scheduled medicines for Eligible Midwives 6447 Contents
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
BOARD OF PHARMACY SPECIALTIES PHARMACOTHERAPY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2015/FOR USE ON FALL 2016 EXAMINATION AND FORWARD UNDERSTANDING THE CONTENT
Doctor of Pharmacy Education Program-Level Ability-Based Outcomes North Dakota State University College of Pharmacy, Nursing, and Allied Sciences The mission of North Dakota State University College of
Section 1: The purpose of this document There are three key components to the Healthcare Science workforce in the UK: 1. Healthcare Science Associates and Assistants who perform a diverse range of task
West Virginia University School of Pharmacy Educational Outcomes Professional Curriculum Approved by the Faculty: October 11, 2013 1 Preamble The School of Pharmacy s educational outcomes (EOs) are designed
Registered School Nurses Scope of Practice INTRODUCTION: This document identifies the fundamental competencies required in each of the three domains of nursing practice, namely: Care Provision and Management,
FIP Pharmacy Information Section Requirements for Drug Information Centres Summary All countries should provide drug information services either independently or as part of a regional network. The service
REPUBLIC OF KENYA MINISTRY OF HEALTH NATIONAL POLICY ON INJECTION SAFETY AND MEDICAL WASTE MANAGEMENT MINISTRY OF HEALTH NATIONAL POLICY INJECTION SAFETY AND MEDICAL WASTE MANAGEMENT FEBRUARY 2007 National
Harness Care Cooperative Ltd Quality primary care services provided through local cooperation Company registration: 06584450 Job Description Job title: Nurse Practitioner /Lead Nurse ACCOUNTIBILITY The
PHARMACY TECHNICIAN STRUCTURED PRACTICAL TRAINING (SPT) - GUIDE Goals This structured practical training program is intended to ensure candidates understand and meet the competencies and standards of practice
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
Nurse Practitioner Mentor Guideline NPAC-NZ Purpose To provide a framework for the mentorship of registered nurses to prepare for Nurse Practitioner (NP) registration from the Nursing Council of New Zealand.
Standards of Practice for Primary Health Care Nurse Practitioners June 2010 (1/14) MANDATE The Nurses Association of New Brunswick is a professional organization that exists to protect the public and to
M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta
Pharmacy Technician Structured Practical Training Program Logbook This logbook outlines the activities that pharmacy technician learners are required to complete in order to demonstrate competencies as
IFMSA Policy Statement Global Policy on Medical Education Location: Taipei, Taiwan. Date of Adoption: August 9 th 2014. Date of Expiry: August 9 th 2017. Summary The International Federation of Medical
Level 8 - Job description for an advanced nurse practitioner in general practice Title: Advanced nurse practitioner in general practice Agenda for Change (AfC) banding: 8 Hours of duty: Responsible to:
Hospital pharmacy technician role / service definition grid To be a competent hospital pharmacy technician, you must be able to complete the required task to the defined standard and to do this on every
Standards of proficiency Operating department practitioners Contents Foreword 1 Introduction 3 Standards of proficiency 7 Foreword We are pleased to present the Health and Care Professions Council s standards
JOB DESCRIPTION JOB TITLE PAY BAND DIRECTORATE / DIVISION DEPARTMENT BASE RESPONSIBLE TO ACCOUNTABLE TO RESPONSIBLE FOR Student Pharmacy Technician Band 4 (1st year 70% of top point on band 4, 2 nd year
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
The College of Family Physicians of Canada Position Statement Prescribing Rights for Health Professionals Introduction The College of Family Physicians of Canada (CFPC) supports models of practice that
Rubric for Evaluating Colorado s Specialized Service Professionals: School Nurses Definition of an Effective School Nurse Effective school nurses are vital members of the education team. They are properly
Page 1 AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 251-11-5517 700 Fax 251-11-5517 844 website: www. africa-union.org 5 th SESSION OF THE AU CONFERENCE OF
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility
School Nurse Section - Introduction The Role of the Credentialed School Nurse Role of the Credentialed School Nurse The California School Nurses Organization (CSNO) position statement: The California School
Personal Assessment Form for RN(NP) Practice for the SRNA Continuing Competence Program (CCP) Completing a personal assessment is a mandatory component of the SRNA CCP. It allows a RN and RN(NP) to strategically
Quality and Performance Improvement Program Description 2016 Introduction and Purpose Contra Costa Health Plan (CCHP) is a federally qualified, state licensed, county sponsored Health Maintenance Organization
STATE OF IOWA TERRY BRANSTAD, GOVERNOR KIM REYNOLDS, LT. GOVERNOR IOW A BO ARD OF MEDICINE MARK BOW DEN, E XECUTIVE DIRECTO R FOR IMMEDIATE RELEASE: October 10, 2014 CONTACT: Mark Bowden, ( 515) 242-3268
Quick Guide For Administrators Based on TIP 52 Clinical Supervision and Professional Development of the Substance Abuse Counselor Contents Why a Quick Guide?...2 What Is a TIP?...3 Benefits and Rationale...4
Medication Management Guidelines for Nurses and Midwives 1. Introduction As the statutory body responsible for the regulation of nursing and midwifery practice in Western Australia (WA), the Nurses & Midwives
Professional COMPETENCIES for Canadian PHARMACY TECHNICIANS at Entry to Practice March 2014 Approved by the National Association of Pharmacy Regulatory Authorities (NAPRA) Board of Directors November 2013,
Professional COMPETENCIES for Canadian PHARMACY TECHNICIANS at Entry to Practice Approved by the National Association of Pharmacy Regulatory Authorities (NAPRA) Board of Directors November 2013, published
Code of Ethics for Pharmacists and Pharmacy Technicians About this document Registration as a pharmacist or pharmacy technician carries obligations as well as privileges. It requires you to: develop and
Canadian Pharmacy Technician Educators Association (CPTEA) Educational Outcomes for Pharmacy Technician Programs in Canada March 2007 Educational Outcomes for Pharmacy Technician Page 1 of 14 Framework
Value added services of pharmaceutical fullline wholesalers Contact GIRP for discussing partnerships + 32 2 777 99 77 firstname.lastname@example.org Selected examples from GIRP s integrated member companies: Please note
2015-16 Rubric for Evaluating Colorado s Specialized Service Professionals: School Nurses Definition of an Effective School Nurse Effective school nurses are vital members of the education team. They are
520 SPECIAL TOPICS IN PHARMACY LAW. (2) Discussion of the legal framework and special legal issues in pharmacy practice. Topics will include application of antitrust laws to pharmacy, patent and trademark
healthcare associated infection A C T I O N G U I D E 1.2 AUSTRALIAN SAFETY AND QUALITY GOALS FOR HEALTH CARE What are the goals? The Australian Safety and Quality Goals for Health Care set out some important
Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacists Network Marie Smith, PharmD and Michlle Breland, PhD University of Connecticut,
Accreditation Standards for Pharmacy Technician Education and Training Programs Introduction These standards have been developed to: protect the public, serve as a guide for pharmacy technician education
The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE In the 2014 APEC Leader s Declaration and Joint Ministerial Statement, it is recognized that the prospect of
Pharmacy Technician Structured Practical Training Program MANUAL AND SUBMISSION FORMS December 2014 (Updated July 2015) *To be reviewed by Supervisor and Pharmacy Technician-in-Training and used in conjunction
Self Care in New Zealand A roadmap toward greater personal responsibility in managing health Prepared by the New Zealand Self Medication Industry Association. July 2009 What is Self Care? Self Care describes
Code of Conduct A Physician Assistant (now associate) (PA) is defined as someone who is: a new healthcare professional who, while not a doctor, works to the medical model, with the attitudes, skills and
Child Care Occupational Standard MQF Level 5 CDC 501 Establish and develop working relationships CDC 502 Support policies, procedures and practice to safeguard children and ensure their inclusion and well-being
Act No. 285 Public Acts of 2014 Approved by the Governor September 23, 2014 Filed with the Secretary of State September 23, 2014 EFFECTIVE DATE: December 22, 2014 STATE OF MICHIGAN 97TH LEGISLATURE REGULAR
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
Canadian Nurse Practitioner Core Competency Framework January 2005 Table of Contents Preface... 1 Acknowledgments... 2 Introduction... 3 Assumptions... 4 Competencies... 5 I. Health Assessment and Diagnosis...
NATIONAL MEDICINAL DRUG POLICY FOR SRI LANKA Preamble Sri Lanka had a partly written Drug Policy from the 1960s. It was written as elements of a policy, beginning from selection of drugs for the government
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In
Professional Standards for Homecare Services in England September 2013 Foreword The Royal Pharmaceutical Society is delighted to publish these professional standards for homecare services. These professional
Page 1 AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 251-11-5517 700 Fax 251-11-5517 844 website: www. africa-union.org 5 th SESSION OF THE AU CONFERENCE OF
Pharmaceutical Management Interventions Through a Drug and Therapeutics Committee (DTC) in Kabul, Afghanistan: Initial Experience After Decades of Neglect Abdul Zahir Siddiqui, 1 Fahima Habibi, 2, Noorulhaq
105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription
Competencies for the nurse practitioner scope of practice Approved by Council September 2008 Nurse practitioner scope of practice Nurse practitioners are expert nurses who work within a specific area of
SaskTech (Guidance Document) An Evaluation and Monitoring Tool For Pharmacy Assistants September 2007 1 TABLE OF CONTENTS Page Introduction...3 Pharmacy Assistant/Technician Training Programs... 4 Pharmacy
National Standards for Safer Better Healthcare June 2012 About the Health Information and Quality Authority The (HIQA) is the independent Authority established to drive continuous improvement in Ireland
Hospital pharmacists as part of the Drug & Therapeutics Committee I EAHP Academy Seminar 20 May, Belgrade Serbia Mag. Gunar Stemer Vienna General Hospital, Pharmacy Department Nothing to disclose. EAHP
Delivering Local Health Care Accelerating the pace of change Delivering Local Integrated Care Accelerating the Pace of Change WG 17711 Digital ISBN 978 1 0496 0 Crown copyright 2013 2 Contents Joint foreword
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
Workers health: global plan of action Sixtieth World Health Assembly 2 SIXTIETH WORLD HEALTH ASSEMBLY SIXTIETH WORLD HEALTH ASSEMBLY WHA60.26 Agenda item 12.13 23 May 2007 Workers health: global plan of
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
QUALIFICATION DETAILS Qualification Title New Zealand Certificate in Pharmacy (Pharmacy Technician) (Level 4) Version 1 Qualification type Certificate Level 4 Credits 75 NZSCED DAS Classification Strategic
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
Introducing... Active Pharmacy service SM Innovative new ways to enhance benefits and reduce costs Did you know... that healthcare costs in Canada have doubled in the last decade?* Added value and cost
Advanced Practice (Public Health) Author: Claire Barley (Head of Professional and Organisational Development) and Kelly McFadyen (Professional and Organisational Development Manager) Date: 2 December 2014